Oak Hill Capital Acquires Majority Stake in Technimark Holdings LLC

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Oak Hill Capital (“Oak Hill“), a New York-based middle-market private equity firm, announced that it had agreed to acquire a controlling stake in Technimark Holdings LLC (“Technimark” or “the Company”) through Oak Hill’s fifth institutional fund, forming a partnership with current investors, Pritzker Private Capital (“PPC”) and management. The terms of the transaction were not disclosed.

Headquartered in Asheboro, North Carolina, Technimark is a leading designer and manufacturer of custom, highly-engineered injection molded components, which it sells to a group of global healthcare, consumer and specialty industrial customers. “We have a great deal of respect for what Technimark has accomplished, including its strong track-record of delivering industry leading quality and service to its customers,” said Brian Cherry, Managing Partner at Oak Hill. “We are delighted to partner with Technimark’s world class management team.”

“Technimark is a fantastic business with industry leading engineering and innovation capabilities and a very impressive list of global customers,” said John Rachwalski, a Partner at Oak Hill. “Thanks to strong leadership and smart, well-executed investments, Technimark is distinctively positioned to capitalize on the trends in its core target markets. We look forward to supporting the Company’s exciting growth agenda over the course of our partnership.”

The management team of Technimark, led by Chief Executive Officer Brad Wellington, will continue to lead the Company and retain a meaningful ownership stake. “Oak Hill is a firm that shares our collaborative culture and our growth vision for the business. We look forward to a successful partnership as we continue investing in Technimark’s manufacturing and innovation capabilities to drive best-in-class results for our customers,” said Wellington.

William Blair & Company served as financial advisor to Oak Hill on the transaction and Goldman Sachs & Co and Wells Fargo Securities, LLC acted as financial advisor to Technimark. Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor to Oak Hill and Kirkland & Ellis LLP is serving as legal counsel to Technimark and PPC.

The transaction is expected to close in the third quarter of 2021 and represents the ninth investment in the Oak Hill Capital Partners V portfolio.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.